Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Tech Connect, Vol. 6, Issue 5: PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

    ... . Rigved Joshi, Manager, New Ventures at CTTC will serve as the Co-PI and Business Mentor on the grant. VenoStent PinPtr is led by Dr. Hak-Joon ...

    steelmk - 11/15/2016 - 4:18pm

  2. Tech Connect, Vol. 7, Issue 8: Breast Cancer Innovation

    ... About CTTC   |   For Faculty Inventors   |   For Industry ... 615.343.2430 | cttc@vanderbilt.edu | www.cttc.co  ...

    steelmk - 11/10/2016 - 7:45am

  3. CTTC co-hosts technology in healthcare event

    ... Freier, Cambridge BioPartners; Hassan Naqvi, Vanderbilt CTTC; Jordan Asher, MissionPoint Health Partners; Kevin Johnson, Vanderbilt; ... Lloyd, Capgemini North America; Bill Taranto, Merk GHI CTTC in collaboration with Merck Global Healthcare Innovation and Cambridge ...

    Anonymous - 05/24/2016 - 8:53am

  4. Grant from Google to support COVID gene expression study

    ... different systems within the body,” said the project’s co-principal investigator,  Jennifer “Piper” Below , PhD, associate ... in the UNC Chapel Hill Gillings School of Global Public Health, and the project’s principal investigator. For the first ...

    sommers - 09/29/2020 - 9:40am

  5. CTTC team presents, participates at 2016 SEMDA meeting

    ... A team of Vanderbilt CTTC staff and engineers attended and presented several Vanderbilt technologies ... Medical Device Association (SEMDA) annual meeting as part of CTTC’s technology marketing efforts. This year, twelve Vanderbilt ...

    steelmk - 02/21/2019 - 9:51am

  6. Targeted light-based therapy for acne

    ... cancer, this technology improves the effectiveness of PDT by co-administering a small molecule therapeutic. This therapeutic activates the ... Additional document url:  /sites/default/files/marketing_projects_attachments/MKT15096.pdf ...

    cttc_admin - 08/09/2023 - 12:48pm

  7. VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

    ... mosquito-borne alphavirus that poses a significant threat to public health in tropical and subtropical regions. Chikungunya disease is ... for months to years. Although mortality is not high, the public health burden is significant: 1.3 billion people live in areas endemic ...

    sommers - 01/29/2021 - 8:45am

  8. New study reveals breakthrough tool to show how much exoskeletons reduce back injury risk

    ... now being used daily in factories, warehouses, construction sites, and other workplaces around the world to relieve physical strain on ...

    sommers - 02/04/2022 - 10:38am

  9. Targeting diabetic kidney disease

    ... active when phosphate molecules attach at specific tyrosine sites in the protein. The phosphorylated tyrosines become the docking sites for a variety of molecules that regulate cell proliferation, maturation ...

    sommers - 02/21/2019 - 9:51am

  10. CTTC team presents, participates at 2015 SEMDA meeting

    ... Medical Device Association (SEMDA) annual meeting as part of CTTC’s technology marketing efforts. This year, two Vanderbilt technologies ... below presenting poster awards), licensing officer with CTTC, served as the chair for the conference's poster session which showcased ...

    nbmas - 10/02/2015 - 10:43am